Hutchison China MediTech Revenue 2014-2019 | HCM

Hutchison China MediTech revenue from 2014 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Hutchison China MediTech Annual Revenue
(Millions of US $)
2019 $205
2018 $214
2017 $241
2016 $216
2015 $178
2014 $87
2013 $37
Hutchison China MediTech Quarterly Revenue
(Millions of US $)
2019-12-31
2019-09-30
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.450B $0.205B
Hutchison China MediTech Limited researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. The Company offers drugs for oncology and autoimmune diseases treatment. Hutchison China MediTech Limited is based in Hong Kong.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $139.911B 24.49
Medtronic (MDT) Ireland $123.362B 16.59
Stryker (SYK) United States $61.082B 19.73
Boston Scientific (BSX) United States $44.176B 19.90
Baxter (BAX) United States $41.692B 25.45
Coloplast (CLPBY) Denmark $30.866B 47.63
Lonza Group Ag (LZAGY) Switzerland $30.841B 0.00
Terumo (TRUMY) Japan $26.173B 32.66
EssilorLuxottica Societe Anonyme (ESLOY) France $23.905B 0.00
ResMed (RMD) United States $22.301B 38.75
Zimmer Biomet Holdings (ZBH) United States $20.285B 12.49
Smith & Nephew SNATS (SNN) United Kingdom $15.852B 0.00
Sunny Optical Technology (SNPTF) China $15.257B 0.00
Insulet (PODD) United States $10.975B 671.46
Bio-Rad Laboratories (BIO) United States $10.447B 48.83
William Demant Holdings (WILYY) Denmark $7.898B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.161B 0.00
Hill-Rom Holdings (HRC) United States $6.805B 19.57
Perrigo (PRGO) Ireland $6.644B 12.11
GN STORE NORD (GNNDY) Denmark $5.673B 29.31
Haemonetics (HAE) United States $5.127B 31.56
Canopy Growth (CGC) Canada $5.052B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Quidel (QDEL) United States $4.340B 38.10
ICU Medical (ICUI) United States $4.090B 26.71
Neogen (NEOG) United States $3.507B 59.41
GW Pharmaceuticals (GWPH) United Kingdom $2.634B 0.00
NuVasive (NUVA) United States $2.600B 20.10
Agios Pharmaceuticals (AGIO) United States $2.425B 0.00
Envista Holdings (NVST) United States $2.397B 0.00
National Vision Holdings (EYE) United States $1.570B 26.46
AtriCure (ATRC) United States $1.310B 0.00
Cardiovascular Systems (CSII) United States $1.252B 0.00
TG Therapeutics (TGTX) United States $1.129B 0.00
Aurora Cannabis (ACB) Canada $1.080B 0.00
Phibro Animal Health (PAHC) United States $0.916B 18.11
NanoString Technologies (NSTG) United States $0.886B 0.00
Aphria (APHA) $0.823B 0.00
VAREX IMAGING (VREX) United States $0.807B 16.78
Cerus (CERS) United States $0.757B 0.00
InMode (INMD) Israel $0.673B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.672B 120.92
PetIQ (PETQ) United States $0.658B 17.91
Eagle Pharmaceuticals (EGRX) United States $0.620B 36.84
Omeros (OMER) United States $0.618B 0.00
OraSure Technologies (OSUR) United States $0.609B 75.61
Quanterix (QTRX) United States $0.532B 0.00
Owens & Minor (OMI) United States $0.529B 14.47
LeMaitre Vascular (LMAT) United States $0.495B 27.88
Lantheus Holdings (LNTH) United States $0.488B 10.97
Surmodics (SRDX) United States $0.424B 48.70
Vapotherm (VAPO) United States $0.420B 0.00
Zynex (ZYXI) United States $0.354B 38.57
Organigram Holdings (OGI) Canada $0.351B 0.00
Meridian Bioscience (VIVO) United States $0.341B 13.74
Utah Medical Products (UTMD) United States $0.331B 23.67
MacroGenics (MGNX) United States $0.289B 0.00
Repro-Med Systems (KRMD) United States $0.285B 179.50
Cytosorbents (CTSO) United States $0.230B 0.00
HEXO (HEXO) $0.224B 0.00
Female Health (VERU) United States $0.213B 0.00
BioLife Solutions (BLFS) United States $0.201B 123.13
Exagen (XGN) United States $0.182B 0.00
Viemed Healthcare (VMD) United States $0.176B 19.87
InfuSystems Holdings (INFU) United States $0.168B 141.33
United Health Products (UEEC) United States $0.155B 0.00
Rockwell Medical (RMTI) United States $0.138B 0.00
Evolus (EOLS) United States $0.136B 0.00
Bovie Medical (APYX) United States $0.122B 0.00
Liberty Health Sciences (LHSIF) Canada $0.115B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.109B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
Chimerix (CMRX) United States $0.091B 0.00
Fonar (FONR) United States $0.091B 6.63
Brainsway (BWAY) Israel $0.076B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.068B 0.00
United-Guardian (UG) United States $0.065B 13.65
MTech Acquisition (KERN) United States $0.065B 0.00
Wound Management Technologies (SMTI) United States $0.061B 0.00
Nephros (NEPH) United States $0.055B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
Surface Oncology (SURF) United States $0.053B 0.00
GUARDION HEALTH (GHSI) United States $0.031B 0.00
ImmuCell (ICCC) United States $0.029B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00
Akers Biosciences Inc (AKER) United States $0.001B 0.00